Frontiers in Neuroscience | Neuropharmacology

Original Research

Published on 04 Nov 2022

Ameliorative effect of vanillin on scopolamine-induced dementia-like cognitive impairment in a mouse model

in Neuropharmacology

Abhinav Anand
Navneet Khurana
Nemat Ali
Abdullah F. AlAsmari
Metab Alharbi
Mohammad Waseem
Neha Sharma

Frontiers in Neuroscience

doi 10.3389/fnins.2022.1005972

5,607 views
11 citations

Review

Published on 03 Nov 2022

Signaling underlying kappa opioid receptor-mediated behaviors in rodents

in Neuropharmacology

Lee-Yuan Liu-Chen
Peng Huang

Frontiers in Neuroscience

doi 10.3389/fnins.2022.964724

5,152 views
10 citations

Editorial

Published on 31 Oct 2022

Editorial: Immune and oxidative pathways in psychiatric disorders

in Neuropharmacology

Angela Maria Casaril

Frontiers in Neuroscience

doi 10.3389/fnins.2022.1073757

1,468 views
1 citation

Review

Published on 26 Oct 2022

Missing pieces in decoding the brain oxytocin puzzle: Functional insights from mouse brain wiring diagrams

in Neuropharmacology

Steffy B. Manjila
Rebecca Betty
Yongsoo Kim

Frontiers in Neuroscience

doi 10.3389/fnins.2022.1044736

5,429 views
10 citations

Original Research

Published on 25 Oct 2022

Oro-mucosal administration of oxytocin using medicated lollipops alters social attention, similar to intranasal and lingual routes: Implications for therapeutic use

in Neuropharmacology

Dan Xu
Qin Li
Qian Zhuang
Yingying Zhang
Shuxia Yao
Weihua Zhao
Keith M. Kendrick

Frontiers in Neuroscience

doi 10.3389/fnins.2022.1022101

3,295 views
11 citations

Review

Published on 20 Oct 2022

Gene regulatory and gene editing tools and their applications for retinal diseases and neuroprotection: From proof-of-concept to clinical trial

in Neuropharmacology

Halit Yusuf Altay
Fatma Ozdemir
Ferdows Afghah
Zeynep Kilinc
Mehri Ahmadian
Markus Tschopp
Cavit Agca

Frontiers in Neuroscience

doi 10.3389/fnins.2022.924917

6,593 views
7 citations

Review

Published on 19 Oct 2022

The use of attention-deficit hyperactivity disorder medications in cardiac disease

in Neuropharmacology

Constantin-Cristian Topriceanu
James C. Moon
Gabriella Captur
Bhathika Perera

Frontiers in Neuroscience

doi 10.3389/fnins.2022.1020961

39,648 views
10 citations

Original Research

Published on 18 Oct 2022

Isoflurane has no effect on cognitive or behavioral performance in a mouse model of early-stage Alzheimer’s disease

in Neuropharmacology

Laura Borgstedt
Sebastian Bratke
Manfred Blobner
Christoph Pötzl
Bernhard Ulm
Bettina Jungwirth
Sebastian Schmid

Frontiers in Neuroscience

doi 10.3389/fnins.2022.1033729

2,958 views
4 citations

Editorial

Published on 18 Oct 2022

Editorial: Central nervous system acting drugs-molecular mechanisms of neuroprotection and neurodegeneration

in Neuropharmacology

Nesrine S. El Sayed
Riham Salah El Dine
Barbara Budzyńska
Anna Boguszewska-Czubara
Jolanta Kotlińska

Frontiers in Neuroscience

doi 10.3389/fnins.2022.1060515

1,578 views
1 citation

Editorial

Published on 17 Oct 2022

Editorial: From bench to bedside, targeting secondary brain damage following intracerebral hemorrhage

in Neuropharmacology

Cheng Gao
Zhong Wang

Frontiers in Neuroscience

doi 10.3389/fnins.2022.1021776

1,764 views

Mini Review

Published on 06 Oct 2022

Long non-coding RNAs: Potential therapeutic targets for epilepsy

in Neuropharmacology

Sen Liu
Min Fan
Meng-Die Ma
Jin-Fang Ge
Fei-Hu Chen

Frontiers in Neuroscience

doi 10.3389/fnins.2022.986874

3,710 views
5 citations

Systematic Review

Published on 05 Oct 2022

Efficacy of miRNA-modified mesenchymal stem cell extracellular vesicles in spinal cord injury: A systematic review of the literature and network meta-analysis

in Neuropharmacology

Zhelun Yang
Jian Rao
Zeyan Liang
Xiongjie Xu
Fabin Lin
Yike Lin
Chunhua Wang
Chunmei Chen

Frontiers in Neuroscience

doi 10.3389/fnins.2022.989295

2,805 views
5 citations

Original Research

Published on 04 Oct 2022

Therapeutic efficacy of matrix metalloproteinase-12 suppression on neurological recovery after ischemic stroke: Optimal treatment timing and duration

in Neuropharmacology

Siva Reddy Challa
Koteswara Rao Nalamolu
Casimir A. Fornal
Billy C. Wang
Ryan C. Martin
Elsa A. Olson
Ammar L. Ujjainwala
David M. Pinson
Jeffrey D. Klopfenstein
Krishna Kumar Veeravalli

Frontiers in Neuroscience

doi 10.3389/fnins.2022.1012812

3,764 views
13 citations

Original Research

Published on 30 Sep 2022

Effects of cannabinoid exposure on short-term memory and medial orbitofrontal cortex function and chemistry in adolescent female rhesus macaques

in Neuropharmacology

Stephen J. Kohut
Lei Cao
Dionyssios Mintzopolous
Shan Jiang
Spyros P. Nikas
Alexandros Makriyannis
Chun S. Zou
J. Eric Jensen
Blaise B. Frederick
Jack Bergman

Frontiers in Neuroscience

doi 10.3389/fnins.2022.998351

2,810 views
5 citations

Original Research

Published on 28 Sep 2022

Sevoflurane exposure may cause dysplasia of dendritic spines and result in fine motor dysfunction in developing mouse through the PI3K/AKT/mTOR pathway

in Neuropharmacology

Linhong Zhong
Xiaofan Ma
Yixuan Niu
Lei Zhang
Zhenyu Xue
Jia Yan
Hong Jiang

Frontiers in Neuroscience

doi 10.3389/fnins.2022.1006175

2,636 views
11 citations

Original Research

Published on 23 Sep 2022

Developmental or adult-onset deletion of neurotensin receptor-1 from dopamine neurons differentially reduces body weight

in Neuropharmacology

Patricia Perez-Bonilla
Jariel Ramirez-Virella
Pooja Menon
Eva Troyano-Rodriguez
Sydney K. Arriaga
Anna Makela
Raluca Bugescu
Michael J. Beckstead
Gina M. Leinninger

Frontiers in Neuroscience

doi 10.3389/fnins.2022.874316

4,813 views
4 citations